Mining for regulatory programs in the cancer transcriptome (original) (raw)

• Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49–54 (2003).
  Article CAS Google Scholar
• Rhodes, D.R. et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. USA 101, 9309–9314 (2004).
  Article CAS Google Scholar
• Segal, E., Friedman, N., Koller, D. & Regev, A. A module map showing conditional activity of expression modules in cancer. Nat. Genet. 36, 1090–1098 (2004).
  Article CAS Google Scholar
• Elkon, R., Linhart, C., Sharan, R., Shamir, R. & Shiloh, Y. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res. 13, 773–780 (2003).
  Article CAS Google Scholar
• Rhodes, D.R. et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1–6 (2004).
  Article CAS Google Scholar
• Matys, V. et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31, 374–378 (2003).
  Article CAS Google Scholar
• Sladek, F.M., Zhong, W.M., Lai, E. & Darnell, J.E. Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4, 2353–2365 (1990).
  Article CAS Google Scholar
• Xanthopoulos, K.G. et al. The different tissue transcription patterns of gene for HNF-1, C/EBP, HNF-3, and HNF-4, protein factors that govern liver-specific transcription. Proc. Natl. Acad. Sci. USA 88, 3807–3811 (1991).
  Article CAS Google Scholar
• Black, B.L. & Olson, E.N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14, 167–196 (1998).
  Article CAS Google Scholar
• O'Donovan, K.J., Tourtellotte, W.G., Millbrandt, J. & Baraban, J.M. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 22, 167–173 (1999).
  Article CAS Google Scholar
• Taniguchi, T., Ogasawara, K., Takaoka, A. & Tanaka, N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623–655 (2001).
  Article CAS Google Scholar
• Caamano, J. & Hunter, C.A. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 15, 414–429 (2002).
  Article CAS Google Scholar
• Rosner, M.H. et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345, 686–692 (1990).
  Article CAS Google Scholar
• Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379–391 (1998).
  Article CAS Google Scholar
• La Thangue, N.B. The yin and yang of E2F-1: balancing life and death. Nat. Cell Biol. 5, 587–589 (2003).
  Article CAS Google Scholar
• Zhu, W., Giangrande, P.H. & Nevins, J.R. E2Fs link the control of G1/S and G2/M transcription. EMBO J. 23, 4615–4626 (2004).
  Article CAS Google Scholar
• Bracken, A.P. et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22, 5323–5335 (2003).
  Article CAS Google Scholar
• Chae, H.D., Yun, J., Bang, Y.J. & Shin, D.Y. Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions. Oncogene 23, 4084–4088 (2004).
  Article CAS Google Scholar
• Muller, H. et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267–285 (2001).
  Article CAS Google Scholar
• DeGregori, J., Kowalik, T. & Nevins, J.R. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell Biol. 15, 4215–4524 (1995).
  Article CAS Google Scholar
• Keenan, S.M., Lents, N.H. & Baldassare, J.J. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression. J. Biol. Chem. 279, 5387–5396 (2004).
  Article CAS Google Scholar
• Cao, R. et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039–1043 (2002).
  Article CAS Google Scholar
• Kleer, C.G. et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA 100, 11606–11611 (2003).
  Article CAS Google Scholar
• Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624–629 (2002).
  Article CAS Google Scholar
• Gilmore, T.D., Kalaitzidis, D., Liang, M.C. & Starczynowski, D.T. The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene 23, 2275–2286 (2004).
  Article CAS Google Scholar
• Houldsworth, J. et al. Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood 103, 1862–1868 (2004).
  Article CAS Google Scholar
• Lossos, I.S. et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc. Natl. Acad. Sci. USA 99, 8886–8891 (2002).
  Article CAS Google Scholar
• Nau, M.M. et al. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature 318, 69–73 (1985).
  Article CAS Google Scholar
• Wong, A.J. et al. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science 233, 461–464 (1986).
  Article CAS Google Scholar
• Zucman, J. et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat. Genet. 4, 341–345 (1993).
  Article CAS Google Scholar
• Jean, D. & Bar-Eli, M. Targeting the ATF-1/CREB transcription factors by single chain Fv fragment in human melanoma: potential modality for cancer therapy. Crit. Rev. Immunol. 21, 275–286 (2001).
  Article CAS Google Scholar
• Johnson, D.G., Cress, W.D., Jakoi, L. & Nevins, J.R. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91, 12823–12827 (1994).
  Article CAS Google Scholar
• Schwab, M., Varmus, H.E. & Bishop, J.M. Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature 316, 160–162 (1985).
  Article CAS Google Scholar
• Sylla, B.S. & Temin, H.M. Activation of oncogenicity of the c-rel proto-oncogene. Mol. Cell Biol. 6, 4709–4716 (1986).
  Article CAS Google Scholar
• Seth, A. & Papas, T.S. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. Oncogene 5, 1761–1767 (1990).
  CAS PubMed Google Scholar
• Lamb, J. et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323–334 (2003).
  Article CAS Google Scholar